Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,738,049 papers from all fields of science
Search
Sign In
Create Free Account
Response Evaluation Criteria in Cancer of the Liver
Known as:
RECICL
Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 revised version). (Kudo M, Kubo…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Clinical Data Interchange Standards Consortium Terminology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Therapy Response Imaging in Hepatobiliary and Pancreatic Malignancies
Sanaz Ameli
,
M. Shaghaghi
,
I. Kamel
,
A. Zaheer
2020
Corpus ID: 214353276
Hepatocellular carcinoma (HCC), cholangiocarcinoma, and pancreatic ductal adenocarcinoma (PDAC) are the most common primary…
Expand
2019
2019
Response Evaluation Criteria in Cancer of the Liver (RECICL 2019 revised version)
M. Kudo
,
M. Ikeda
,
+9 authors
N. Kokudo
Kanzo
2019
Corpus ID: 86797975
Review
2017
Review
2017
Radiologic criteria of response to systemic treatments for hepatocellular carcinoma.
F. Tovoli
,
M. Renzulli
,
A. Granito
,
R. Golfieri
,
L. Bolondi
Hepatic Oncology
2017
Corpus ID: 52168901
Sorafenib has been the only approved systemic therapy for hepatocellular carcinoma until very recently. However, the radiologic…
Expand
2015
2015
Real-Life Clinical Practice with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Center Experience Second Analysis
T. Arizumi
,
K. Ueshima
,
+13 authors
M. Kudo
Digestive Diseases
2015
Corpus ID: 23151746
Objectives: Sorafenib has become a standard therapy for advanced hepatocellular carcinoma following the demonstration of…
Expand
2013
2013
Efficacy of transcatheter arterial chemoembolization with miriplatin-lipiodol water-soluble contrast agent emulsion in patients with hepatocellular carcinoma.
K. Okimoto
,
S. Ogasawara
,
+9 authors
O. Yokosuka
Anticancer Research
2013
Corpus ID: 24709938
AIM To evaluate the therapeutic efficacy of transcatheter arterial chemoembolization (TACE) using miriplatin emulsion in…
Expand
2013
2013
座談会 Round Table Discussion 肝細胞癌の治療効果判定 : RECIST,mRECIST,RECICL
工藤 正俊
,
土谷 薫
,
角谷 眞澄
2013
Corpus ID: 175871047
2011
2011
肝細胞癌のソラフェニブ治療効果判定におけるRECIST,modified RECIST,RECICL基準の比較
英介 村上
,
浩 相方
,
+9 authors
一彰 茶山
2011
Corpus ID: 79183976
RECIST, mRECIST and RECICL are criteria for evaluating the therapeutic response of hepatocellular carcinoma and there are several…
Expand
2011
2011
肝細胞癌のソラフェニブ治療効果判定における RECIST, modified RECIST, RECICL 基準の比較
村上 英介
,
相方 浩
,
+9 authors
茶山 一彰
2011
Corpus ID: 172795282
2010
2010
Response Evaluation Criteria in Cancer of the Liver (RECICL 2021 revised version)
M. Kudo
,
Shouji Kubo
,
+6 authors
M. Makuuchi
Kanzo
2010
Corpus ID: 72105491
1.はじめに 「肝癌治療直接効果判定基準」 (Response Evaluation Criteria in Cancer of the Liver:RECICL)は,1993 年 10月に第 1版が作成され,1994…
Expand
2005
2005
EXPERIENCIA DE RECICL EXPERIENCIA DE RECICL EXPERIENCIA DE RECICL EXPERIENCIA DE RECICL EXPERIENCIA DE RECICL AJE
J. A. Salazar
2005
Corpus ID: 134134332
In the modern World, there is a growing trend to use unconventional construction materials, in order to look for solutions to…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required